Skip to main content

Table 1 miR-363 expression and clinicopathological features in 49 osteosarcoma

From: MiR-363 suppresses cell migration, invasion, and epithelial-mesenchymal transition of osteosarcoma by binding to NOB1

Clinicopathological featuresCases (n = 49)miR-363 expressionP value*
23 high (%)26 low (%)
Gender    
 Male2512 (48.0)13 (52.0)0.879
 Female2411 (45.8)13 (51.2) 
Age (years)    
 ≤ 182113 (61.9)8 (38.1)0.124
 > 182810 (35.7)18 (64.3) 
Tumor size (mm)    
 ≤ 5.02214 (63.6)8 (36.4)0.035*
 > 5.0279 (33.3)18 (66.7) 
TNM stage    
 I–II2415 (62.5)9 (37.5)0.032*
 III–IV258 (32.0)17 (68.0) 
Lymph node metastasis    
 0–22817 (60.7)11 (39.3)0.026*
 > 2216 (28.6)15 (71.4) 
Metastasis    
 Absent2314 (60.9)9 (39.1)0.066
 Present269 (34.6)17 (65.4) 
NOB1    
 Low expression238 (34.8)15 (65.2)0.011*
 High expression2615 (57.7)11 (42.3) 
  1. *P values are calculated with chi-square test